Press "Enter" to skip to content

Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recalls

New steps to strengthen the process of initiating voluntary recalls

Original source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm636462.htm

Also Read:   FDA announces Project Facilitate to assist physicians seeking access to unapproved therapies for patients with cancer